Amedeo Smart

Free Medical Literature Service


 

Amedeo

Arrhythmias

  Free Subscription

05.02.2024

1 Am Heart J
3 Am J Cardiol
2 Ann Thorac Surg
2 Cardiovasc Res
2 Circ Arrhythm Electrophysiol
2 Circ Genom Precis Med
4 Circulation
3 Eur Heart J
2 Heart
2 Int J Cardiol
5 J Cardiovasc Electrophysiol
1 J Electrocardiol
7 J Interv Card Electrophysiol
2 J Thromb Thrombolysis
1 Pacing Clin Electrophysiol
1 PLoS One
1 Stroke



    Am Heart J

  1. CAPPATO R, Mark DB, Silverstein AP, Noseworthy PA, et al
    Regional Differences in Outcomes with Ablation Versus Drug Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Am Heart J. 2024 Jan 31:S0002-8703(24)00018-8. doi: 10.1016/j.ahj.2024.
    >> Share


    Am J Cardiol

  2. LUIS SA, Michelena HI, Nkomo VT
    Navigating the Complex Landscape of Atrial Functional Mitral Regurgitation: Insights, Challenges, and Emerging Interventions.
    Am J Cardiol. 2023 Dec 14:S0002-9149(23)01380.
    >> Share

  3. SUGIYAMA Y, Miyashita H, Yokoyama H, Ochiai T, et al
    Risk assessment of permanent pacemaker implantation after transcatheter aortic valve implantation in patients with pre-existing right bundle branch block.
    Am J Cardiol. 2023 Dec 14:S0002-9149(23)01379.
    >> Share

  4. REDEL-TRAUB G, Elnabawi YA, Gurel K, Sudesh S, et al
    Predictors of Transthoracic Impedance in Patients Who Underwent Elective Electrical Cardioversion.
    Am J Cardiol. 2024;213:146-150.
    >> Share


    Ann Thorac Surg

  5. WYLER VON BALLMOOS MC, Hui DS, Mehaffey JH, Malaisrie SC, et al
    The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation.
    Ann Thorac Surg. 2024 Jan 27:S0003-4975(24)00057.
    >> Share

  6. YOUNG AM, Strobel RJ, Martin LW
    Future Directions in Atrial Fibrillation Prophylaxis and Risk Stratification.
    Ann Thorac Surg. 2024 Jan 23:S0003-4975(24)00065.
    >> Share


    Cardiovasc Res

  7. MORENO-MANUEL AI, Macias A, Cruz FM, Gutierrez LK, et al
    The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of Short QT Syndrome type 3.
    Cardiovasc Res. 2024 Jan 23:cvae019. doi: 10.1093.
    >> Share

  8. NGUYEN MN, Hooper C, Stefanini M, Vrellaku B, et al
    Why is early-onset atrial fibrillation uncommon in patients with Duchenne Muscular Dystrophy? Insights from the mdx mouse.
    Cardiovasc Res. 2024 Jan 25:cvae022. doi: 10.1093.
    >> Share


    Circ Arrhythm Electrophysiol

  9. HOLMSTROM L, Bednarski B, Chugh H, Aziz H, et al
    Artificial Intelligence Model Predicts Sudden Cardiac Arrest Manifesting With Pulseless Electric Activity Versus Ventricular Fibrillation.
    Circ Arrhythm Electrophysiol. 2024 Jan 29:e012338.
    >> Share

  10. ASATRYAN B, Murray B, Gasperetti A, McClellan R, et al
    Unraveling Complexities in Genetically Elusive Long QT Syndrome.
    Circ Arrhythm Electrophysiol. 2024 Jan 24:e012356.
    >> Share


    Circ Genom Precis Med

  11. SHAUER A, Horowitz-Cederboim S, Mor-Shaked H, Durst R, et al
    Calmodulinopathy Associated Long QT Syndrome, Hypertrophic Cardiomyopathy With Excessive Trabeculation in a 14-Year-Old Girl Presenting With Ventricular Fibrillation.
    Circ Genom Precis Med. 2024 Jan 23:e004163. doi: 10.1161/CIRCGEN.123.004163.
    >> Share

  12. VAN OPBERGEN CJM, Narayanan B, B Sacramento C, Stiles KM, et al
    AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular Cardiomyopathy in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans.
    Circ Genom Precis Med. 2024 Jan 30:e004305. doi: 10.1161/CIRCGEN.123.004305.
    >> Share


    Circulation

  13. LEE SY, Lee BK
    Palpitations and Recurrent Syncope in a Young Woman.
    Circulation. 2024;149:402-405.
    >> Share

  14. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    >> Share

  15. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
    Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Circulation. 2024;149:379-390.
    >> Share

  16. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    >> Share


    Eur Heart J

  17. ELLIOTT PM
    Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093.
    >> Share

  18. YOUNES H, Rao S, Marrouche N
    Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
    Eur Heart J. 2024 Jan 24:ehad872. doi: 10.1093.
    >> Share

  19. BRIENESSE S, Passman R, Freedman B
    Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification.
    Eur Heart J. 2024 Jan 23:ehad874. doi: 10.1093.
    >> Share


    Heart

  20. VAN HATTUM JC, Daems JJN, Verwijs SM, Wismans LV, et al
    Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
    Heart. 2024;110:254-262.
    >> Share

  21. TEIGER E, Eschalier R, Amabile N, Rioufol G, et al
    Left atrial appendage closure in very elderly patients in the French National Registry.
    Heart. 2023 Oct 9:heartjnl-2023-322871. doi: 10.1136/heartjnl-2023-322871.
    >> Share


    Int J Cardiol

  22. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
    Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
    >> Share

  23. UKITA K, Egami Y, Nohara H, Kawanami S, et al
    Predictors of 30-day survival after emergent percutaneous coronary intervention following ventricular Tachyarrhythmias complicating acute myocardial infarction.
    Int J Cardiol. 2024 Jan 21:131806. doi: 10.1016/j.ijcard.2024.131806.
    >> Share


    J Cardiovasc Electrophysiol

  24. GARDZIEJCZYK P, Piotrowski R, Krynski T, Sikorska A, et al
    Bipolar catheter ablation with dedicated radiofrequency system for highly refractory ventricular arrhythmia-Does the rate of success depend on arrhythmia origin?
    J Cardiovasc Electrophysiol. 2024 Jan 31. doi: 10.1111/jce.16186.
    >> Share

  25. ROWIN EJ, Wadid M, Maron MS, White M, et al
    Assessing the impact of atrial fibrillation on symptoms and quality of life in hypertrophic cardiomyopathy.
    J Cardiovasc Electrophysiol. 2024 Jan 30. doi: 10.1111/jce.16192.
    >> Share

  26. QI D, Guan X, Liu X, Liu L, et al
    Slow conduction velocity predicts atrial fibrillation recurrence after radiofrequency ablation.
    J Cardiovasc Electrophysiol. 2024 Jan 28. doi: 10.1111/jce.16193.
    >> Share

  27. ZENG L, Chen S, Zeng R, Hu H, et al
    CLOSE protocol versus lower ablation index value for paroxysmal atrial fibrillation: A randomized noninferior clinical trial.
    J Cardiovasc Electrophysiol. 2024 Jan 28. doi: 10.1111/jce.16194.
    >> Share

  28. SHIMIZU Y, Yoshitani K, Kuriyama T, Mori K, et al
    The effect of an initial catheter ablation with an adjunctive ethanol infusion into the vein of Marshall on persistent atrial fibrillation.
    J Cardiovasc Electrophysiol. 2024 Jan 28. doi: 10.1111/jce.16191.
    >> Share


    J Electrocardiol

  29. LIU X, Li M, Chen J, Wu J, et al
    Association between left bundle branch block and ventricular septal mid-wall fibrosis in patients with preserved left ventricular ejection fraction.
    J Electrocardiol. 2024;83:21-25.
    >> Share


    J Interv Card Electrophysiol

  30. CALVERT P, Ding WY, Griffin M, Bisson A, et al
    Silent pulmonary veins at redo ablation for atrial fibrillation: Implications and approaches.
    J Interv Card Electrophysiol. 2024 Jan 23. doi: 10.1007/s10840-024-01750.
    >> Share

  31. COMPAGNUCCI P, Casella M
    Atrial tachyarrhythmia recurrence after cryobaloon ablation: does thickness imply failure?
    J Interv Card Electrophysiol. 2024 Jan 23. doi: 10.1007/s10840-024-01747.
    >> Share

  32. NEKIC A, Prepolec I, Pasara V, Bogdanic JE, et al
    Treatment of atrial fibrillation with second-generation cryoballoon followed by contact-sensing radiofrequency catheter ablation for arrhythmia recurrences-results of a 5-year follow-up.
    J Interv Card Electrophysiol. 2024 Jan 23. doi: 10.1007/s10840-024-01752.
    >> Share

  33. KATAOKA N, Imamura T
    Association between depression, quality of life, and ablation for atrial fibrillation.
    J Interv Card Electrophysiol. 2024 Jan 23. doi: 10.1007/s10840-024-01739.
    >> Share

  34. KEEGAN R, Garmendia F, Gregorietti F, Urruti R, et al
    Very high-power and short-duration radiofrequency ablation for atrial fibrillation in a Latin American low-volume private center.
    J Interv Card Electrophysiol. 2024 Jan 23. doi: 10.1007/s10840-024-01756.
    >> Share

  35. COSTA GA, Alfie A, Speranza R, Olivera C, et al
    Unveiling duodromic atrioventricular reentrant tachycardia in Wolff-Parkinson-White syndrome: a unique circuit showing His bundle dissociation with two septal accessory pathways in close anatomical proximity.
    J Interv Card Electrophysiol. 2024 Jan 24. doi: 10.1007/s10840-024-01749.
    >> Share

  36. FRANCA MRQ, Morillo CA, Carmo AAL, Mayrink M, et al
    Efficacy and safety of catheter ablation for atrial fibrillation in elderly patients: a systematic review and meta-analysis.
    J Interv Card Electrophysiol. 2024 Jan 31. doi: 10.1007/s10840-024-01755.
    >> Share


    J Thromb Thrombolysis

  37. TRILLER DM, Wilson AS, Allen AL, Burnett AE, et al
    Digital dashboards for direct oral anticoagulant surveillance, intervention and operational efficiency: uptake, obstacles, and opportunities.
    J Thromb Thrombolysis. 2024;57:107-116.
    >> Share

  38. DE LUCENA LA, Freitas MAA, Souza AKC, Silva CHA, et al
    Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials.
    J Thromb Thrombolysis. 2024 Jan 28. doi: 10.1007/s11239-023-02945.
    >> Share


    Pacing Clin Electrophysiol

  39. ZHOU ZX, Zheng C, Hu YD, Lin JF, et al
    Mapping and ablation of ventricular arrhythmias arising from the left ventricular summit.
    Pacing Clin Electrophysiol. 2024 Jan 30. doi: 10.1111/pace.14932.
    >> Share


    PLoS One

  40. KAWAJI T, Bao B, Hojo S, Tezuka Y, et al
    Variation in the frozen lesion size according to the non-occluded application duration and technique for cryoballoon ablation.
    PLoS One. 2024;19:e0297263.
    >> Share


    Stroke

  41. YANG X, Lippert J, Dekkers M, Baillieul S, et al
    Impact of Comorbid Sleep-Disordered Breathing and Atrial Fibrillation on the Long-Term Outcome After Ischemic Stroke.
    Stroke. 2024 Jan 26. doi: 10.1161/STROKEAHA.123.042856.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016